The Pirbright Institute

Funded awards at The Pirbright Institute.

Funded awards
510
Published Funding
£332.9M
Average published award
£654K
Active funded awards
24

Amounts are published for 509 of 510 funded awards. Data as of 16 July 2026.

See funded awards Open the Map

The biggest topic here is Infection & Immunity — 407 grants (80%). The busiest year was 2009, with 71 grants.

Funded Awards by Year

View data table
YearFunded awards
200646
200734
200822
200971
201035
201125
201253
201327
201440
201528
201616
201721
201817
201910
20207
202113
202212
202319
202410
20254

Grants

High ContainmentThe Pirbright InstituteBBSRC£43.1M2017Completed
Low ContainmentThe Pirbright InstituteBBSRC£21.2M2017Completed
BBSRC National Bioscience Research Infrastructure: High Containment Services and Science PlatformsThe Pirbright InstituteBBSRC£15.5M2023Active
Science ServicesThe Pirbright InstituteBBSRC£15.1M2017Completed
Molecular and Systems VirologyThe Pirbright InstituteBBSRC£8.1M2017Completed
BBSRC National Bioscience Research Infrastructure: Low Containment Services and Science PlatformsThe Pirbright InstituteBBSRC£6.3M2023Active
Host Responses to Viral Infection: A fundamental understanding of immune responseThe Pirbright InstituteBBSRC£4.2M2023Active
Virus Life Cycles at Multiple Scales: Biology of virus-infected cellsThe Pirbright InstituteBBSRC£4.0M2023Active
Virus Life Cycles at Multiple Scales: Virus-host interactions controlling species-specific outcomesThe Pirbright InstituteBBSRC£2.7M2023Active
Host Responses to Viral Infection: Differential outcomes of viral infectionsThe Pirbright InstituteBBSRC£1.8M2023Active
A bivalent vaccine to reduce the risk of Nipah virus outbreaksThe Pirbright InstituteInnovateUK£1.5M2024Completed
Host Responses to Viral Infection: Enhancing protective response in vertebrate hostsThe Pirbright InstituteBBSRC£1.3M2023Active
21-EEID US-UK Collab: Multi-scale infection dynamics from cells to landscapes: foot-and-mouth disease viruses in African buffaloThe Pirbright InstituteBBSRC£1.2M2023Active
US-UK-China Collab: Understanding the Impact of Poultry Vaccination on H5Nx Avian Influenza Virus Evolution and Ecosystem DynamicsThe Pirbright InstituteBBSRC£999K2024Active
Understanding and controlling lumpy skin disease in Indian cattleThe Pirbright InstituteUKRI£840K2024Active
FLU:Trailmap: Transmission and risk of avian influenza: learning more to advance preparednessThe Pirbright InstituteBBSRC£792K2024Completed
DNA-launched Nipah virus vaccines and therapeuticsThe Pirbright InstituteUKRI£773K2025Active
How does Musashi 1 enhance Zika virus replication?The Pirbright InstituteBBSRC£766K2021Completed
Pathogenesis, immunity, and control of coronaviruses in a large natural host animal, the pigThe Pirbright InstituteBBSRC£750K2023Active
REPRODIVAC – Next-generation vaccines and diagnostics to prevent livestock reproductive diseases of worldwide impactThe Pirbright InstituteUKRI£738K2022Active

Page 1 of 3